Home > Newsletters > Devices & Diagnostics Letter > Role of Authorized Rep Explained in EU Guideline
Devices & Diagnostics Letter
March 12, 2012 | Vol. 39 No. 11
Role of Authorized Rep Explained in EU Guideline
The European Commission has published a final guideline aimed at clarifying the relationship between devicemakers and their authorized representatives (AR). It also spells out European Union (EU) member states’ expectations of ARs and their client relationships.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.